Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 24 of 31 for:    CTPS1

A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00574106
Recruitment Status : Unknown
Verified August 2009 by GAAD Medical Research Institute Inc..
Recruitment status was:  Active, not recruiting
First Posted : December 14, 2007
Last Update Posted : August 17, 2009
Sponsor:
Information provided by:
GAAD Medical Research Institute Inc.

Brief Summary:
Cancer is the number one killer in Canada and in most countries of the world. The investigators' initial assessment indicates that far infrared radiation has the potential to cure cancer.

Condition or disease Intervention/treatment Phase
Neoplasms Radiation: Far Infrared Radiation Phase 1

Detailed Description:

The investigators have identified a combination of methods for possible cancer treatment as follows:

  1. Energy specific far infrared radiation (5 μm to 20 μm ). No x-rays, gamma rays etc. are used.
  2. Oxygenation of the body cells
  3. pH balance
  4. Lifestyle changes, or
  5. A combination of chemotherapy and (1), (2), (3) and (4) above.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation for Cancer Treatment
Study Start Date : February 2008
Actual Primary Completion Date : August 2009
Estimated Study Completion Date : October 2009

Arm Intervention/treatment
1
Infrared Radiation
Radiation: Far Infrared Radiation
Far Infrared Radiation (5μm to 20μm wavelength)




Primary Outcome Measures :
  1. The effect of far infrared radiation on cancerous tumours [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. The effect on far infrared treatment on different kinds of cancer. [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All cancer patients

Exclusion Criteria:

  • non-cancer patients

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00574106


Locations
Layout table for location information
Canada, Ontario
The Centre for Incurable Diseases
Toronto, Ontario, Canada, M4V 1L5
Sponsors and Collaborators
GAAD Medical Research Institute Inc.
Investigators
Layout table for investigator information
Principal Investigator: Ken Nedd, M.D. GAAD Medical Research Institute Inc.
Study Director: Kwasi Donyina, Ph.D. GAAD Medical Research Institute Inc.

Layout table for additonal information
Responsible Party: Dr. Kwasi Donyina, The Centre for Incurable Diseases, GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier: NCT00574106     History of Changes
Other Study ID Numbers: GAAD-CAN-CTP1
First Posted: December 14, 2007    Key Record Dates
Last Update Posted: August 17, 2009
Last Verified: August 2009
Keywords provided by GAAD Medical Research Institute Inc.:
Cancer
Tumors